Congenital leukocyte adherence deficiency
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
We aimed to report the characteristics of leukocyte adhesion deficiency-I (LAD-I) and four novel mutations in the ITGB2 gene in a Chinese cohort.
|
30919141 |
2019 |
Congenital leukocyte adherence deficiency
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte Adhesion Deficiency I (LAD-I) is a primary immunodeficiency caused by single gene mutations in the CD18 subunit of β2 integrins which result in defective transmigration of neutrophils into the tissues.
|
25741691 |
2015 |
Congenital leukocyte adherence deficiency
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Disabling mutations in integrin-mediated cell signaling have been a major focus of interest over the last decade for patients affected with leukocyte adhesion deficiency-III (LAD-III).
|
25854317 |
2015 |
Congenital leukocyte adherence deficiency
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency (LAD) I is a well-described genetic disorder in which leukocytes are unable to migrate to sites of inflammation due to mutations in the ITGB2 gene coding for the β subunit of β2 (CD18) leukocyte integrins.
|
24344107 |
2014 |
Congenital leukocyte adherence deficiency
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
CD18(+) leukocyte levels were >2% following infusion of vector-transduced cells leading to ongoing reversal of the CLAD phenotype for >4 years.
|
23531552 |
2013 |
Congenital leukocyte adherence deficiency
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Kindlin-3 is a novel integrin activator in hematopoietic cells, and its deficiency leads to immune problems and severe bleeding, known as leukocyte adhesion deficiency III (LAD-III).
|
22564402 |
2012 |
Congenital leukocyte adherence deficiency
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Gene therapy of canine leukocyte adhesion deficiency using lentiviral vectors with human CD11b and CD18 promoters driving canine CD18 expression.
|
20859258 |
2011 |
Congenital leukocyte adherence deficiency
|
0.200 |
Biomarker
|
disease |
BEFREE |
Kindlin-3 is a key lymphocyte function-associated antigen-1 (LFA-1) coactivator deleted in leukocyte adhesion deficiency-III (LAD-III).
|
21536861 |
2011 |
Congenital leukocyte adherence deficiency
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
In the disorder leukocyte adhesion deficiency III (LAD-III), integrins on platelets and leukocytes are expressed but fail to function and this leads to severe bleeding and infections at an early age.
|
20357244 |
2010 |
Congenital leukocyte adherence deficiency
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
The effect of gentamicin-induced readthrough on a novel premature termination codon of CD18 leukocyte adhesion deficiency patients.
|
21103413 |
2010 |
Congenital leukocyte adherence deficiency
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
A novel point mutation in CD18 causing leukocyte adhesion deficiency in a Chinese patient.
|
20529581 |
2010 |
Congenital leukocyte adherence deficiency
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Novel integrin-dependent platelet malfunction in siblings with leukocyte adhesion deficiency-III (LAD-III) caused by a point mutation in FERMT3.
|
20216991 |
2010 |
Congenital leukocyte adherence deficiency
|
0.200 |
Biomarker
|
disease |
BEFREE |
These results indicate that the EF1alphaS promoter-driven CD18 expression in the context of a RRLSIN lentiviral vector does not lead to sufficient numbers of CD18(+) neutrophils in vivo to reverse the CLAD phenotype when used in a non-myeloablative transplant regimen in dogs.
|
20164857 |
2010 |
Congenital leukocyte adherence deficiency
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
These symptoms are consistent with but more severe than those reported for people with leukocyte adhesion deficiency III (LAD-III).
|
19234460 |
2009 |
Congenital leukocyte adherence deficiency
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency II (LAD II) is a rare congenital disease caused by defective fucosylation leading to immuno-deficiency and psychomotor retardation.
|
16455955 |
2006 |
Congenital leukocyte adherence deficiency
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency II (LAD II) belongs to a group of human congenital diseases in which the interactions of leukocytes with the vascular endothelium are strongly impaired.
|
16956371 |
2006 |
Congenital leukocyte adherence deficiency
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Two novel CD18 mutations were identified in a patient who was a compound heterozygote with type 1 leukocyte adhesion deficiency and whose phenotype was typical except that he exhibited hypertrophic scarring.
|
14512306 |
2004 |
Congenital leukocyte adherence deficiency
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
We have defined the defect in a child with severe leukocyte adhesion deficiency-1 (LAD) as resulting from a single amino acid shift in CD18 (from a C to T mutation at position 533) that prevents heterodimerization with the CD11 antigens to produce beta(2) integrins-the first reported patient homozygous for this defect.
|
12749013 |
2003 |
Congenital leukocyte adherence deficiency
|
0.200 |
Biomarker
|
disease |
BEFREE |
In fact, the absence of CD18 results in type-1 leukocyte adhesion deficiency (LAD-1).
|
12377933 |
2002 |
Congenital leukocyte adherence deficiency
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency II (LAD II) is a rare congenital disease which is caused by a defect in fucosylation of glycoconjugates.
|
12476046 |
2002 |
Congenital leukocyte adherence deficiency
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
CD18 is a key molecule of the AC, as CD18 defects abrogate the adhesion of PMN and cause leukocyte adhesion deficiency, an immunodeficient trait.
|
11528520 |
2001 |
Congenital leukocyte adherence deficiency
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency II (LAD II) is characterized by the lack of fucosylated glycoconjugates, including selectin ligands, causing immunodeficiency and severe mental and growth retardation.
|
11326279 |
2001 |
Congenital leukocyte adherence deficiency
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Leucocyte adhesion deficiency (LAD) is a hereditary disorder caused by mutations in the CD18 (beta2 integrin) gene.
|
11703376 |
2001 |
Congenital leukocyte adherence deficiency
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
Neutrophils isolated from a child with severe leukocyte adhesion deficiency 1 (LAD1) had a complete absence of expression of the CD11/CD18 beta2 integrin family of adhesion molecules, and were shown to be deficient in the in vitro adhesion and migration properties.
|
10564719 |
2000 |
Congenital leukocyte adherence deficiency
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency-1 (LAD-1) is the result of mutations in the beta2 subunit of the CD11/CD18 integrins, LFA-1, Mac-1, p150,95 and alphadbeta2.
|
10936446 |
2000 |